This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Stocks in play: Cardiol Therapeutics Inc.

Baystreet - Tue Apr 14, 6:46AM CDT

Announced that Cardiol's President and Chief Executive Officer David Elsley, will participate in a live interview on X with Barchart.com today at 12:00 p.m. EDT. Cardiol Therapeutics Inc. shares T.CRDL are trading unchanged at $1.89.